Latest AI and machine learning research in parkinson's disease for healthcare professionals.
Deep brain stimulation (DBS) for treatment-resistant depression (TRD) is challenged by significant individual variability in efficacy and unclear neural circuit mechanisms. To address this, a cross-species, multi-level electrophysiological study was conducted to elucidate the core underlying pathophysiology and reveal the precise therapeutic mechanisms of DBS. Based on the clinical trial (NCT04530...
Accurately quantifying motor characteristics in Parkinson's disease is crucial for monitoring disease progression and optimizing treatment strategies. The finger-tapping test is a standard motor assessment. Clinicians visually evaluate a patient's tapping performance and assign an overall severity score based on tapping amplitude, speed, and irregularity. Simultaneous video recording during the st...
BACKGROUND: Parkinson's disease (PD) and multiple system atrophy with parkinsonian type (MSA-P) share various motor and nonmotor symptoms, complicatin...
The global burden of Parkinson's disease (PD) is projected to double by 2050, with early-onset cases demonstrating accelerated progression and limited...
Modern radiology requires sustained attention, rapid decision-making, and emotional resilience amid increasing imaging volumes, diagnostic complexity,...
With emerging single-cell transcriptomics data, deep learning approaches have enabled the diagnosis of neurodegenerative disorders such as Parkinson's...
Machine learning (ML)-based methods have been proposed as a potential approach for identifying candidate drugs to be repurposed as disease-modifying t...
Intrinsically disordered proteins (IDPs) play central roles in signalling, regulation, and disease, yet they remain a severe challenge for current art...
Nanoparticle-based drug delivery faces persistent challenges, including complex fabrication processes and limited lesional accumulation. Here we intro...
BACKGROUND: Parkinson's disease (PD) is a neurodegenerative disorder treated with Levodopa, but long-term use often causes motor complications like "w...
BACKGROUND: Artificial intelligence (AI)-enabled wearable devices are rapidly emerging in rehabilitation and motor function assessment for patients wi...
Parkinson's disease (PD), the second most common neurodegenerative disorder, affects patients and caregivers worldwide. There is a growing need for te...
Cognitive decline is a major non-motor complication in early Parkinson's disease (PD), but predicting its progression remains challenging. Using data ...
Understanding motion and 3D structure from dynamic scenes is a fundamental computer vision challenge. Unsupervised learning addresses the high cost of...
Parkinson's disease (PD) is a progressive neurodegenerative disorder that profoundly affects patients' quality of life. Early and accurate diagnosis i...
INTRODUCTION: Global ageing populations require accessible, non-invasive tools for early detection and monitoring of neurological chronic and neurodeg...
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, including tremor, rigidity, and postural insta...
With remarkably tunable porosity and modular chemistry, metal-organic frameworks (MOFs) present a versatile platform for photocatalytic hydrogen (H2) ...
Parkinson's disease (PD) risk and progression are influenced by a complex interplay of genetic, environmental, and internal factors. Environmental exp...
The brain is a highly complex organ, exhibiting a highly dynamic chemical environment, playing crucial role in coordinating pathophysiological process...